Rijneveld A, van der Holt B, de Weerdt O, et al. Randomized phase III HOVON-100 study of clofarabine combined with standard treatment in adult patients with newly diagnosed ALL. 24th Congress of EHA, abstract PS937.
Veilig stoppen met ibrutinib en venetoclax bij minimale restziekte CLL
jun 2022 | Leukemie